Ladenburg Thalmann Starts NovaBay Pharmaceuticals (NBY) at Buy

September 18, 2019 6:41 AM EDT Send to a Friend
Ladenburg Thalmann analyst Jeffrey Cohen initiates coverage on NovaBay Pharmaceuticals ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login